Cargando…

Cannabidiol-enriched cannabis extraction product in Parkinson’s disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital

OBJECTIVES: The objective of this study was to assess cannabidiol-enriched cannabis extraction product (CBDEP) efficacy in patients with Parkinson’s disease (PD). MATERIALS AND METHODS: Forty patients with PD were randomly assigned to the sublingual CBDEP (n = 20) or placebo (n = 20) group. All pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanjanarangsichai, Auempa, Mitarnun, Witoon, Mitarnun, Wenika, Pangwong, Wilasinee, Laoharattanahirun, Nutchaya, Kajornrith, Warut, Junlaor, Panomporn, Nonghan, Pawarin, Witthayapirote, Wannisa, Sangkarom, Gorawan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894020/ https://www.ncbi.nlm.nih.gov/pubmed/36743777 http://dx.doi.org/10.25259/JNRP-2022-6-19

Ejemplares similares

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Vaping of Cannabis, Cannabidiol, and Synthetic Cannabis Among US Sexual Minority Youths
por: Liu, Jessica, et al.
Publicado: (2023)

Medical cannabis and cannabidiol: A new harvest for Malawi
por: Bandawe, Gama
Publicado: (2022)

Assessing the adaptive role of cannabidiol (CBD) in Cannabis sativa defense against cannabis aphids
por: MacWilliams, Jacob, et al.
Publicado: (2023)

Comparison of conventional polymerase chain reaction and routine blood smear for the detection of Babesia canis, Hepatozoon canis, Ehrlichia canis, and Anaplasma platys in Buriram Province, Thailand
por: Rucksaken, Rucksak, et al.
Publicado: (2019)

Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model
por: Ewing, Laura E., et al.
Publicado: (2019)

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
por: Capodice, Jillian L., et al.
Publicado: (2021)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
por: De Briyne, Nancy, et al.
Publicado: (2021)

Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap
por: Cleirec, Grégoire, et al.
Publicado: (2022)

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
por: Viana, Milena de Barros, et al.
Publicado: (2022)

Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users
por: Beale, Camilla, et al.
Publicado: (2018)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

Bioactive Hemp Clothing Modified with Cannabidiol (CBD) Cannabis sativa L. Extract
por: Zimniewska, Malgorzata, et al.
Publicado: (2021)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
por: Kicman, Aleksandra, et al.
Publicado: (2020)

Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration
por: Kutanzi, Kristy R., et al.
Publicado: (2020)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa)
por: Chianese, Giuseppina, et al.
Publicado: (2022)

Correlations among morphological and biochemical traits in high‐cannabidiol hemp ( Cannabis sativa L.)
por: Stack, George M., et al.
Publicado: (2023)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
por: Chetia, Swapnali, et al.
Publicado: (2020)

Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
por: Rapin, Lucile, et al.
Publicado: (2021)

A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana
por: Grassa, Christopher J., et al.
Publicado: (2021)

Stable Isotope Ratio Analysis for Authentication of Natural Antioxidant Cannabidiol (CBD) from Cannabis sativa
por: Perini, Matteo, et al.
Publicado: (2023)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences
por: Stasiłowicz-Krzemień, Anna, et al.
Publicado: (2023)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
por: Hua, Daniel Ying-Heng, et al.
Publicado: (2023)

Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
por: Englund, Amir, et al.
Publicado: (2022)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
por: Pérez-Acevedo, Ana Pilar, et al.
Publicado: (2020)

Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022)

Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
por: Anderson, Lyndsey L., et al.
Publicado: (2021)

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
por: Casey, Sherelle L., et al.
Publicado: (2022)

Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke
por: Hindelang, Pascal, et al.
Publicado: (2022)

Long-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus
por: Aguiar, Andrey F. L., et al.
Publicado: (2023)

Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
por: Lukhele, Sindiswa T., et al.
Publicado: (2016)

An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
por: Pagano, Ester, et al.
Publicado: (2016)

Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy
por: Aguirre-Velázquez, Carlos G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_95a5qtl5rodm05etk6smkdesgj